Solís CU, Calvopiña BSJ, Martínez LJP

Language: Spanish
References: 0
Page: 1-13
PDF size: 401.67 Kb.

ABSTRACT

Introduction: Rheumatic diseases are considered systemic diseases because they affect any organ or organ system of the human body, within them the nervous system.
Objective: To identify the main neuropsychiatric manifestations that appears in the course of rheumatic diseases.
Methods: Descriptive study in 827 patients with rheumatic diseases treated at the National Center of Rheumatology in the period from January to September 2017.
Results: Average age of 49.3 years, predominance of females (75.7 years)%), white skin color (69.3%) and disease progression time between 1 and 5 years (42.7%). Rheumatoid arthritis (42.44%), systemic lupus erythematosus (26.48%) and fibromyalgia (16.32%) were the most representative rheumatic diseases. The most reported neuropsychiatric manifestations were headache (63.24%), cognitive alterations (33.01%) and peripheral polyneuropathies (30.96%). Neuropsychiatric manifestations occurred more frequently in patients with a time of evolution greater than 5 years (64.50%).
Conclusions: The rheumatic diseases most represented were rheumatoid arthritis, systemic lupus erythematosus and fibromyalgia, however, the highest percentage of neuropsychiatric manifestations reported were lupus, Sjögren's syndrome and antiphospholipid syndrome. Headache, cognitive alterations, peripheral polyneuropathies, insomnia and radiculopathies were the predominant neuropsychiatric manifestations. The increase in the time of evolution of the disease conditions the appearance of neuropsychiatric manifestations in rheumatic patients.